Unknown

Dataset Information

Elucidating the specificity of non-heparin-based conformational activators of antithrombin for factor Xa inhibition.


ABSTRACT:

Introduction

Antithrombin, the principal inhibitor of coagulation proteases, requires allosteric activation by its physiological cofactor, heparin or heparin sulfate to achieve physiologically permissible rates. This forms the basis of heparin's use as a clinical anticoagulant. However, heparin therapy is beset with severe complications, giving rise to the need to search new non-heparin activators of antithrombin, devoid of these complications and with favorable safety profiles.

Materials and methods

We chose some representative organic compounds that have been shown to be involved in coagulation modulation by affecting antithrombin and applied a blind docking protocol to find the binding energy and interactions of the modified (sulfated) versus unmodified organic scaffolds.

SUBMITTER: Rashid Q 

PROVIDER: S-EPMC3961949 | biostudies-literature | 2014 Jan

REPOSITORIES: biostudies-literature